# LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders

> **NCT03153579** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 46 (actual)

## Conditions studied

- Patients
- Anxiety Disorders

## Interventions

- **DRUG:** LSD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03153579
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-23
- **Primary completion:** 2021-12-15
- **Final completion:** 2021-12-15
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153579, "LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03153579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*